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Abstract: Physical activity (PA) has been identified as beneficial for many diseases and health 
disorders, including sarcopenia. The positive influence of PA interventions on sarcopenia has 
been described previously on many occasions. Current reviews on the topic include studies with 
varied PA interventions for sarcopenia; nevertheless, no systematic review exploring the effects 
of PA in general on sarcopenia has been published. The main aim of this study was to explore 
the relationship between PA and sarcopenia in older people on the basis of cross-sectional and 
cohort studies. We searched PubMed, Scopus, EBSCOhost, and ScienceDirect for articles 
addressing the relationship between PA and sarcopenia. Twenty-five articles were ultimately 
included in the qualitative and quantitative syntheses. A statistically significant association 
between PA and sarcopenia was documented in most of the studies, as well as the protective 
role of PA against sarcopenia development. Furthermore, the meta-analysis indicated that PA 
reduces the odds of acquiring sarcopenia in later life (odds ratio [OR] =0.45; 95% confidence 
interval [CI] 0.37–0.55). The results of this systematic review and meta-analysis confirm the 
beneficial influence of PA in general for the prevention of sarcopenia.
Keywords: aging, sarcopenia, physical activity
Introduction
Although diseases related to the aging process are problematic themselves, they rarely 
occur in isolation and the effects of one may spark the onset of another. As such 
ailments progress, the importance of physical activity (PA) remains high, with previous 
research confirming that regular PA is essential for healthy aging.1 Specifically, PA 
plays a substantial role in lowering the risk of coronary heart disease,2 obesity,3 type 2 
diabetes,4 hypertension,5 peripheral vascular disease,6 high cholesterol,7 osteoporosis,8 
osteoarthritis,9 and chronic obstructive pulmonary disease.10 Although PA may have 
an indirect impact on some health aspects, it has a direct impact on muscle quality 
and quantity.11
Sarcopenia, which was first described by Rosenberg in 198912 as the progressive 
decrease in muscle mass and strength during aging, is a syndrome that is directly 
affected by PA.13–15 Soon after sarcopenia was defined, muscle mass assessment 
had been recommended as the main sarcopenia diagnosing method. Baumgartner 
et al16 proposed that the appendicular skeletal muscle mass index (ASMMI) should 
be the main indicator, and the cutoff point was established as two standard devia-
tions below the mean of a young reference group. Even though this measurement 
is always expressed in relative terms (muscle mass in kilograms divided by body 
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height in meter squared, resulting in kg/m2), many different 
names have been suggested, eg, appendicular lean mass 
index (ALMI), fat-free mass index (FFMI), relative skeletal 
muscle mass index (RSMI), and muscle mass index (MMI), 
and occasionally skeletal muscle mass (SMM) alone serves 
as an indicator of sarcopenia. Computed tomography (CT) 
and magnetic resonance imaging (MRI) are gold standards 
for measuring muscle mass in research. The dual-energy 
X-ray absorptiometry (DXA) is the preferred alternative 
method for research and clinical use;17 however, bioelectrical 
impedance analysis (BIA) has been found as a relevant 
alternative.18 Except these methods, the mid-upper arm 
muscle circumference (MAMC) has been proposed as an 
alternative tool for muscle mass estimation.19 Later, several 
groups were formed for sarcopenia consensus on definition 
and diagnosis in Europe – the European Working Group on 
Sarcopenia in Older People (EWGSOP),17 in Asia – the Asian 
Working Group for Sarcopenia (AWGS),20 and except them 
the International Working Group on Sarcopenia (IWGS).21 
These groups recommended including muscle strength 
and physical performance measurement as the additional 
methods for sarcopenia diagnosing. Currently, the EWGSOP 
algorithm is the most widely used method in research and 
in clinical practice.
Previous research has shown that physical inactivity 
contributes to the development of sarcopenia,22,23 and other 
studies have shown that PA increases muscle strength24,25 
and muscle mass26,27 in older adults. Therefore, a strong 
link has emerged between PA and a lower prevalence of 
sarcopenia.28–31 Specifically, resistance training is generally 
considered to be the best countermeasure for preventing 
sarcopenia.11,32–38
Although many reviews and meta-analyses have sum-
marized the effects of individual or combined interventions 
(eg, resistance training and nutritional supplementation) on 
sarcopenia, a systematic review and meta-analysis of the 
effects of PA defined as general activity that requires more 
energy than resting metabolic rate (eg, exercising, strength-
ening, walking, working in the garden, and so on) on sar-
copenia has not been published. Therefore, the main aim of 
this systematic review and meta-analysis was to describe the 
relationship between PA and the presence of sarcopenia.
Methods
This systematic review and meta-analysis, in accordance 
with the recommendations and criteria as outlined in the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement,39 focused on cross-
sectional and cohort studies.
Criteria for considering studies 
for this study
To be included in the analyses, studies had to meet the fol-
lowing conditions: only data from cross-sectional studies and 
follow-up or baseline datasets of longitudinal cohort studies 
were included, date of publication 1989–2017, English 
language, and participants have to be older than 40 years. As 
PA, there were considered every activity requiring increased 
energy output without regard of frequency and intensity, 
sarcopenia has to be diagnosed by some of the standard rec-
ommendation. There had to be data presented from regression 
models, which included PA as the independent variable and 
sarcopenia as the dependent variable, and odds ratio (OR) 
had to be used as the effect size in those regression models 
for the systematic review. For the meta-analysis, the raw 
data reporting numerically PA habits by both sarcopenic and 
nonsarcopenic individuals had to be presented.
Search methods for identification 
of studies
Appropriate articles were manually identified through 
searches using four electronic databases: PubMed, Scopus, 
EBSCOhost, and ScienceDirect and through the reference 
lists of publications identified in this search. The search 
stream that was used in all the databases is presented in 
Table 1. This process was conducted by the first and third 
authors; the searches were done by the first and last authors 
independently. There was no disagreement between those 
coauthors during the process. The articles were collected 
and sorted using the software EndNote X5 for managing 
bibliographies.
Data collection and analysis
All abstracts were explored by the first and third authors 
independently with the aim of identifying relevant articles. 
During the first step of this process, duplicate articles and 
reviews were removed, then full texts of the remaining 
articles were systematically examined for inclusion or 
exclusion, and the articles lacking the required information 
about PA and sarcopenia were removed. Subsequently, the 
remaining articles were included in the synthesis. Addi-
tionally, the aforementioned protocol was completed on 
relevant articles that were identified within the reference 
lists of the articles identified through database searching. 
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After collection of the relevant articles, the Newcastle-
Ottawa Scale (NOS) was used to assess the quality of 
nonrandomized studies in meta-analyses to eliminate the 
risk of bias.40 This was carried out independently by the 
fourth and fifth authors. There was no disagreement between 
them during the process.
Measures of effect sizes
The Cochran-Mantel-Haenszel statistical method41 based on a 
fixed-effect model was used to calculate an effect size of PA 
on sarcopenia in the meta-analysis. The OR was calculated 
as the effect size of PA on sarcopenia. In this article, the 
OR estimated the odds of demonstrating sarcopenia while 
accounting for PA. An OR less than 1 favors PA, indicating 
that PA decreases the risk (odds) of sarcopenia, and an OR 
greater than 1 suggests that PA increases the risk (odds) of 
sarcopenia. A sensitivity analysis was carried out to reach 
the best estimation. During the sensitivity analysis, those 
studies that might have had an influence on heterogeneity 
because of publication bias were removed. Through the sen-
sitivity analysis, the best OR estimation represented by the 
highest value of a test for the overall effect (Z) taking into 
account heterogeneity and publication bias was calculated. 
An index I2, which does not depend upon the number of 
studies, the type of outcome data, or the choice of treatment 
effect, was used to quantify the impact of heterogeneity 
and to assess inconsistency. I2 can be readily calculated 
from basic results obtained from a typical meta-analysis as 
I2=100% × (Q − df )/Q, where Q is standard Cochran’s het-
erogeneity statistic and df the degrees of freedom. A rough 
guide to interpretation of I2 is as follows: 0 to 40% might not 
be important, 30% to 60% may represent moderate heteroge-
neity, 50% to 90% may represent substantial heterogeneity, 
and 75% to 100% represents considerable heterogeneity.42 
Funnel plots were used for visualizing biases.43A funnel plot 
is a simple scatter plot of exposing the effect estimated from 
individual studies against some measures of each study’s 
size or precision.44 Statistics were carried out using Review 
Manager 5.3.
Results
Description of studies and study 
population
Figure 1 summarizes the yield of the search process. Of 
354 articles identified as potentially relevant by the database 
searching, 19 were included. An additional six articles iden-
tified through article reference lists were added. Excluded 
articles are presented in Table S1. Ultimately, 25 total studies 
were included in the qualitative and quantitative synthe-
ses, comprised of 17 cross-sectional30,31,45–59 and 8 cohort 
studies.29,60–66 From these 25 articles, 20 were used in the 
systematic review and 14 were used in the meta-analysis: 
some articles were used for both, but all 25 articles were 
used in one way or another. Data from 40,007 individuals 
(21,222 males and 18,785 females) were obtained from all 
25 studies. The mean age of the participants was 71.7±4.9 
for nonsarcopenic males and 74.9±5.6 for sarcopenic males 
and 73.1±4.7 for nonsarcopenic females and 76.1±5.0 for 
sarcopenic females. All participants were over 60 years 
old apart from subjects within four studies: Beavers et al 
(.40 years old),45 de Castro et al (55–68 years old),46 Castillo 
et al (55–98 years old),62 and Park et al (.50 years old).55 
The age ranged from 40 to 106 years. Participants lived in 
a community in 23 cases, one time in a nursing home,50 and 
one time participants were recruited from a hospital.53 PA 
was quantified using several different methods, but the most 
common was a self-report questionnaire. In most studies, PA 
was divided into several categories. Sarcopenia diagnostics 
Table 1 Search strategies used with four databases to identify articles describing the relationship between sarcopenia and physical 
activities
Database  
(yield)
Search terms Record identified  
through searching
PubMed Search (sarcopenia[Title]) AND (“physical activit*”) AND  
(cross-sectional OR cohort)
85
Scopus (TITLe (sarcopenia) AND TITLe-ABS-KeY (“physical  
activit*”) AND TITLe-ABS-KeY (cross-sectional OR cohort))
54
eBSCOhost TI sarcopenia AND TX “physical activit*” AND TX (cross- 
sectional OR cohort)
182
ScienceDirect TITLe (sarcopenia) and TITLe-ABSTR-KeY ((“physical activit*”)  
AND (cross-sectional OR cohort))
22
Note: January 4, 2017 – record identified through database searching: 343.
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were based on body composition measurements in most 
cases. The EWGSOP algorithm was used in seven studies, 
and AWGS criteria and IWGS criteria were each used one 
time (Table 2). The quality of the included studies was suffi-
cient according to the NOS score, and no study was excluded 
due to that analysis (Table S2).
Systematic review
Most of the regression models suggested that PA might 
help preserve muscle mass because only four of 32 ORs 
were above 1, and only one study49 estimated PA to be a 
significant risk factor for sarcopenia in females. However, 
13 of 32 regression models estimated PA to be a significant 
protective factor against sarcopenia in older people (Table 3). 
Additionally, six of nine regression models estimated that 
physical inactivity was a significant risk factor for sarcopenia 
in older people (Table 4).
Meta-analysis
In all the analyses, the article by Goodman et al49 stand 
out of the funnel plot that signalized the increased risk of 
bias and for the same reason the article by Park et al55 was 
excluded during sensitivity analysis in the analysis males 
and females together.
For males, data from eight studies were initially included 
in the first analysis, with one study49 later excluded due to pub-
lication bias, thereby resulting in acceptable heterogeneity, 
from I2=73% to I2=4%. After the exclusion of this study, the 
OR (95% confidence interval [CI]) for males (n=3,881) was 
0.46 (0.37–0.58), Cochran Q =5.2, df=5 (P=0.390), indicating 
that PA reduced the odds of males suffering from sarcopenia. 
The test for overall effect was quite strong Z=6.50, which 
was statistically significant (P,0.00001). The forest plot is 
shown in Figure 2.
For females, data from seven studies were included in the 
first analysis, but data from Goodman et al49 were excluded 
for the same reason, reducing heterogeneity from I2=75% to 
an acceptable I2=29%. After the exclusion of this study, the 
OR (95% CI) for females (n=6,234) was 0.65 (0.52–0.81), 
Cochran Q =7.8, df=5 (P=0.290) indicating that PA reduced 
the odds of females demonstrating sarcopenia. The test for 
overall effect was weaker than in males at Z=3.79; however, 
it was still statistically significant (P,0.0001). The forest 
plot is shown in Figure 3.
Figure 1 Flowchart showing how the reviewed articles were identified and selected.
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????
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??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
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Table 2 Summary of studies describing the classification of PA and sarcopenia diagnostics
Study Designa Classification of PA
Sarcopenia diagnostics
Aggio et al60 Cohortb Physical monitoring: accelerometry
ewGSOP algorithm,17 SMM (kg) by MAMC,72 the lowest two-fifths of the MAMC 
distribution
Akune et al29 Cohortb Survey: categorization of past PA based on yes/no
Survey: categorization of past current walking habit based on yes/no
ewGSOP algorithm,17 SMI (kg/m2) by BIA; cutoff 7.0 kg/m2 for males and 5.8 kg/m2 for 
females
Atkins et al61 Cohortb Survey: current PA classified as: inactive, occasional, light, moderate, moderately vigorous, 
vigorous
FFMI (kg/m2) by BIA, ,1st quartile of the distribution of FFMI; cutoff 15.96 kg/m2
Beavers et al45 Cross-sectional Survey: current PA classified as: inactive ,4, low 4–11, moderate 12–20, high .20 times 
per month
SMM (kg) by BIA, sarcopenia class I and II of ,1 SD, respectively, ,2 SD of young reference 
group from this study
Castillo et al62 Cohortb Survey: regular PA three or more times per week – yes/no
FFM (kg) by BIA, ,2 SD of a young reference group from Pichard et al study73
de Castro 
et al46
Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version74
ALMI (kg/m2) by DXA, ,1 SD of a young reference group from this study, cutoff 7.3 kg/m2 
for females
da Silva et al47 Cross-sectional Survey: categorization of past PA based on yes/no
SMI (kg/m2) by BIA, cutoff 16.7 kg/m2 adopted from Atkins et al study75
Domiciano 
et al63
Cohortb An interviewer-mediated standardized questionnaire adapted from National Health 
Interview Survey Basic Questionnaire76
RSMI (kg/m2) by DXA, cutoff 5.45 kg/m2 for females adopted from Baumgartner et al study16
Dutra et al48 Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version74,77
ewGSOP algorithm, SMI (kg/m2) by the Lee equation,78 cutoff 6.75 kg/m2 for females 
adopted from Janssen et al study79
Figueiredo et al64 Cohortb An interviewer-mediated standardized questionnaire adapted from National Health 
Interview Survey Basic Questionnaire76
ASMMI (kg/m2) by DXA, cutoff 7.26 kg/m2 for males adopted from Baumgartner et al study16
Goodman et al49 Cross-sectional Survey: average level of PA each day classified as: low, moderate, heavy
SMI (kg/m2) by DXA, sarcopenia class I ,1SD of a young reference group from this study
Kim et al30 Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version77
ASMMI (kg/m2) by DXA, ,2 SD of a young reference group from this study, cutoff 
6.52 kg/m2 for males
Landi et al50 Cross-sectional Minimum Data Set assessment form for the Nursing Home (MDS-NH)80,81
ewGSOP algorithm, SMI (kg/m2) by BIA, cutoff 8.87 kg/m2 for males and 6.42 kg/m2 for 
females adopted from NHANeS III
Lau et al51 Cross-sectional Survey: categorization of load-bearing exercise based on yes/no
ASMMI (kg/m2) by DXA, ,2.0 SD of a young reference group from this study
Lin et al52 Cross-sectional Survey: categorization of regular exercise habits based on yes/no
ewGSOP algorithm, SMI (kg/m2) by DXA, ,2 SD of a young reference group from 
this study
Martinez et al53 Cross-sectional Survey: categorization of PA prior admission less than 2× per week based on yes/no
MMI (kg/m2) by the Lee equation,78 #20th percentile, cutoff 8.90 kg/m2 for males and 
6.37 kg/m2 for females
Murphy et al54 Cross-sectional Survey: PA was assessed according to kcal/wk spent by exercising in the prior week 
as: ,500, 500–1,499, .1,500 kcal/wk
ALMI (kg/m2) by DXA, #20th percentile, cutoff 7.95 kg/m2 for males and 6.24 kg/m2 for females
Park et al55 Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version77
SMI (kg/m2) by DXA, ,2 SD of a young reference group from this study
Rolland et al65 Cohortc Survey: categorization of recreational PA for $1 h/wk for the past month or more based on 
yes/no
SMI (kg/m2) by DXA, ,2 SD of a reference population from the Rosetta Study,82 cutoff 
5.45 kg/m2 for females
(Continued)
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When combining males and females (nine studies), and 
after excluding two studies49,55 through sensitivity analysis, 
data from the overall population (n=4,605) showed the stron-
gest estimation with an OR (95% CI) of 0.45 (0.37–0.55), 
Cochran Q =8.1, df=6 (P=0.230) indicating that PA reduced 
the odds of patients suffering from sarcopenia. The test for 
overall effect was strong at Z=7.76 (P,0.00001), and het-
erogeneity was sufficiently acceptable I2=26%. The forest 
plot from this analysis is presented in Figure 4.
Discussion
An emerging body of evidence shows that PA plays a 
preventive role against many diseases such as coronary 
heart disease, obesity, type 2 diabetes, hypertension, 
peripheral vascular disease, high cholesterol, osteoporosis, 
osteoarthritis, and chronic obstructive pulmonary disease. 
Data from our systematic review and meta-analysis, similar 
to that of previous authors,14,15 also show that PA protects 
against sarcopenia. Our results are also in concordance with 
Table 2 (Continued)
Study Designa Classification of PA
Sarcopenia diagnostics
Ryu et al31 Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version77
ASMMI (kg/m2) by DXA, ,2 SD of a young reference group from this study
Silva Alexandre 
et al56
Cross-sectional International Physical Activity Questionnaire (IPAQ) – long version74
ewGSOP algorithm,17 SMI (kg/m2) by the Lee equation,78 #20th percentile, cutoff 
8.90 kg/m2 for males and 6.37 kg/m2 for females
Tramontano 
et al57
Cross-sectional Global Physical Activity Questionnaire (GPAQ)83
IwGS criteria,21 ASMMI (kg/m2) by DXA, cutoff 7.23 kg/m2 for males and 5.67 kg/m2 for 
females
volpato et al58 Cross-sectional Survey: PA was divided as: low, moderate/high
ewGSOP algorithm,17 SMI (kg/m2) by BIA, cutoff 8.87 kg/m2 for males and 6.42 kg/m2 for 
females according to ewGSOP17
Yu et al66 Cohortd Physical Activity Scale of the elderly (PASe)84
ewGSOP algorithm,17 SMI (kg/m2) by DXA, the lowest quintile, cutoff 6.52 kg/m2 for males 
and 5.44 kg/m2 for females
Zeng et al59 Cross-sectional Survey: engaging in physical exercise at least once a week and lasting for 30 min or 
more – yes/no
AwGS criteria,20 SMI (kg/m2) by BIA
Notes: aAs stated by the authors. bFollow-up dataset. cBaseline dataset. dBaseline to 2 years.
Abbreviations: PA, physical activity; ewGSOP, european working Group on Sarcopenia in Older People; SMM, skeletal muscle mass; MAMC, mid-upper arm muscle 
circumference; SMI, skeletal muscle mass index; BIA, bioelectrical impedance analysis; FFMI, fat-free mass index; SD, standard deviation; ALMI, appendicular lean mass index; 
DXA, dual-energy X-ray absorptiometry; RSMI, relative skeletal muscle mass index; AwGS, Asian working Group for Sarcopenia.
Table 3 Relationship between sarcopenia and physical activity, according to multiple regression models
Study N Variable Status Multiple logistic regression models 
adjusted for
OR (95% CI)
Females
Akune et al29 651 Current walking habits Yes vs no Age and BMI 0.75 (0.39–1.44)
exercise habits in middle age Yes vs no Age and BMI 0.55 (0.27–1.13)
Castillo et al62 1,006 exercise 3+ times/wk Yes vs no Age, alcohol use, and current 
smoking status
0.51 (0.30–0.89)*
de Castro 
et al46
91 Physical activity level – Age, total cholesterol, LDL, HDL, 
diabetes, wHR, wC, CI, wHeR, 
and BMI
0.54 (0.13–2.27)
Goodman 
et al49
374 Average level of physical 
activity each day
Moderate vs low Unadjusted 1.30 (1.01–1.75)*
Heavy vs low Unadjusted 1.14 (0.40–4.23)
Ryu et al31 1,324 Physical activity level Moderate vs low Age 1.01 (0.65–1.57)
High vs low Age 0.76 (0.45–1.29)
Males
Akune et al29 349 Current walking habits Yes vs no Age and BMI 0.60 (0.28–1.27)
exercise habits in middle age Yes vs no Age and BMI 0.48 (0.22–1.03)
Castillo et al62 694 exercise 3+ times/wk Yes vs no Age, alcohol use, and current 
smoking status
0.77 (0.39–1.55)
(Continued)
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Table 3 (Continued)
Study N Variable Status Multiple logistic regression models 
adjusted for
OR (95% CI)
Figueiredo  
et al64
399 Physical activity Yes vs no Age, BMI, race, smoking, and total femur 
bone mineral density
0.28 (0.08–0.95)*
Goodman  
et al49
551 Average level of physical 
activity each day
Moderate vs low Unadjusted 0.79 (0.62–1.01)
Heavy vs low Unadjusted 0.57 (0.29–1.13)
Kim et al30 1,156 3 or more days of vigorous 
activity of at least 20 min 
per day
– Age, BMI, smoking habit, alcohol 
drinking, family income, education, and 
protein intake
0.55 (0.23–1.31)
5 or more days of moderate-
intensity activity of at least 
30 min/d
– Age, BMI, smoking habit, alcohol 
drinking, family income, education, and 
protein intake
0.59 (0.26–1.36)
5 or more days of walking of 
at least 30 min/d
– Age, BMI, smoking habit, alcohol 
drinking, family income, education, and 
protein intake
0.49 (0.29–0.83)*
Strength exercise: 2 or more 
days/wk
– Age, BMI, smoking habit, alcohol 
drinking, family income, education and 
protein intake
0.59 (0.24–1.48)
Flexibility exercise: 2 or more 
days/wk
– Age, BMI, smoking habit, alcohol 
drinking, family income, education and 
protein intake
1.21 (0.61–2.40)
Ryu et al31 940 Physical activity level Moderate vs low Age 0.65 (0.41–1.04)
High vs low Age 0.29 (0.15–0.56)*
Females and males together
Akune et al29 1,000 Current walking habits
exercise habits in middle age
Yes vs no
Yes vs no
Age and BMI
Age and BMI
0.69 (0.42–1.12)
0.53 (0.31–0.90)*
Beavers et al45 7,544 Physical activity level High vs none Age, BMI, protein intake, serum uric acid 0.80 (0.70–1.00)*
Med vs none Age, BMI, protein intake, serum uric acid 0.70 (0.60–1.00)*
Low vs none Age, BMI, protein intake, serum uric acid 0.80 (0.60–1.00)*
da Silva et al47 253 Past physical activity (PPA) Yes vs no Unclear 0.41 (0.20–0.82)*
Landi et al50 122 1 h or more exercises per day Never or less than 1 h/d Unadjusted 0.37 (0.12–0.99)*
Murphy et al54 2,355 Physical activity 500–1,499 vs ,500 kcal/wk Unclear 0.87 (0.70–1.06)
.1,500 vs ,500 kcal/wk Unclear 0.77 (0.60–0.97)*
Yo et al66 3,142 PASe total score – Age, demographics, socioeconomic status, 
medical history, lifestyle factors, cognitive 
function, IADL impairments, and BMI
0.99 (0.98–0.99)*
Zeng et al59,a 461 Physical exercise Yes vs no Unclear 0.27 (0.09–0.79)*
Notes: aSarcopenia was considered as low gait speed. *Statistically significant.
Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index; PASE, Physical Activity Scale of the Elderly; LDL, low-density lipoproteins; HDL, high-density 
lipoproteins; wHR, waist-hip relation; wC, waist circumference; CI, conicity index; wHeR, waist-height relation; IADL, instrumental activity of daily living.
Table 4 Relationship between sarcopenia and physical inactivity, according to multiple regression models
Study Sex N Variable Multiple logistic 
regression models 
adjusted for
Status OR (95% CI)
Atkins et al61 Males 4,252 Physically inactive Age – 1.43 (1.15–1.76)*
Dutra et al48 Females 173 Sedentary Crude vs active 2.96 (1.23–7.12)*
Lau et al51 Males 262 Regular exercise Age No vs yes 1.51 (0.68–3.38)
Females 265 Regular exercise Age No vs yes 1.10 (0.40–3.00)
Lin et al52 Together 761 exercise Crude No vs yes 3.09 (1.98–4.82)*
exercise Age, sex, marital 
status, regular 
exercise habits, 
comorbidity status
No vs yes 2.70 (1.66–4.41)*
Martinez et al53 Together 110 Physical activity less 
than 2× per week
Unclear 3.40 (1.10–10.90)*
Silva Alexandre 
et al56
Together 1,149 Sedentary lifestyle Unclear vs active lifestyle 0.66 (0.42–1.06)
Tramontano et al57 Together 222 Low physical 
activity levels
Unclear Recommended 
physical activity levels
3.80 (1.30–10.90)*
Note: *Statistically significant.
Abbreviations: OR, odds ratio; CI, confidence interval.
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Figure 2 The forest plot of effect sizes for males.
Abbreviation: CI, confidence interval.
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Figure 3 The forest plot of effect sizes for females.
three recent meta-analyses: one including eight trials report-
ing that exercise can increase gait speed, balance, and activi-
ties of daily living in frail older adults,67 another incorporating 
19 trials that concluded that exercise has some benefits in frail 
older people,68 and a third synthesizing data from 18 studies, 
which provided evidence that physical exercise therapy could 
improve mobility and physical functioning even among older 
patients with mobility problems and physical disability.69 
Although there is conformity among our work and these 
meta-analyses, it should be pointed out that the other meta-
analyses were focused mostly on randomized controlled 
trials while our meta-analysis combined diverse studies of 
PA, which was typically identified by self-report. It is worth 
mentioning that the method of acquiring PA data largely 
varies among studies. In involved studies, some people per-
formed PA such as regular housework, gardening, or did an 
occupational activity involving the carrying of light or heavy 
objects. They also occasionally walked, did slow swimming, 
played doubles tennis, volleyball, did vigorous exercise such 
as running, climbing, fast cycling, fast swimming, football, 
basketball, rope jumping, squash, and singles tennis. In the 
study of Aggio et al,60 participants wore an accelerometer 
for 7 days during waking hours, which was removed only 
for water-based activities.
As seen in Table 2, many different methods were used to 
diagnose sarcopenia, which may result in increased risk of 
publication bias, which has been previously described.70 For 
example, Goodman et al49 used only one standard deviation 
below a young reference group as the cutoff value for diag-
nosing sarcopenia, which may have caused a large percentage 
of the population to be falsely identified as sarcopenic. 
Another weakness of our review was that we did not include 
subgroup analyses, as there were only a few studies for 
making subgroups according to sarcopenia diagnosing or 
several different physical activities as well as metabolic 
equivalent of task (MET). Therefore, we recommend that 
future research should unify diagnostic methods according 
to consensus. This may improve our knowledge of how PA 
plays a role in sarcopenia protection. Finally, it should be 
mentioned that we used only four databases and the terms 
“sarcopenia” and “physical activity” may not have unearthed 
100% of the research in this area. However, we believe that 
despite this limitation, the review is beneficial, as it is the first 
systematic review and meta-analysis on the topic.
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Figure 4 The forest plot of effect sizes for males and females.
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In summary, when participants did at least some PA, they 
had better odds of avoiding sarcopenia. Our results support 
the recommendation of the American College of Sports 
Medicine (ACSM) and the American Heart Association 
(AHA) that regular PA, including occupational activity, 
aerobic sport activity, and muscle-strengthening activity, is 
essential for healthy aging.71
Most likely, the association between PA and the protec-
tion of muscle mass is common sense. However, this is the 
first systematic review and meta-analysis to confirm this 
association on the basis of cross-sectional and cohort studies. 
Moreover, it seems that the type of PA that is undertaken is 
not important, because except for one study that showed an 
association between PA and worsening sarcopenia, studies 
including several different PA showed that PA acts as a 
protective factor against sarcopenia.
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